• CRISPR Therapeutics Announces Planned European Clinical Trial

    Clinical Informatics News Brief | CRISPR Therapeutics today announced the submission of a Clinical Trial Application (CTA) today for CTX001 in β-thalassemia. CTX001 is an investigational CRISPR gene-edited autologous hematopoietic stem cell therapy for patients suffering from β-thalassemia and sickle cell disease. The clinical trial will begin in 2018 in Europe.

    Dec 7, 2017
  • Amazon Cancels Pharmaceutical License Application In Maine

    CNBC |  Amazon appears to have canceled a pharmaceutical wholesaler application in the state of Maine, analysts at RBC Capital Markets pointed out Tuesday, raising further questions about the tech giant's plans to enter the pharmacy space.

    Dec 6, 2017
  • Zika Virus Clinical Trial Says Vaccine Safe Immune Response

    MiamiHerald |  A Zika vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases has cleared the first phase of clinical trials. Findings were published in The Lancet, a medical journal.

    Dec 5, 2017
  • Circulation, Lyft Announce Medical Transportation Partnership

    Clinical Informatics News  Circulation today announced a preferred partnership with Lyft, the fastest growing rideshare company in the US. This partnership will expand non-emergency transportation options for Circulation’s clients nationwide, which currently number more than 1,000 healthcare facilities. Starting today, all Circulation users can schedule Lyft rides directly through Circulation’s on-demand patient-centric digital transportation platform.

    Dec 5, 2017
  • Bracket, Johnson & Johnson, Bioclinica, And More: News From November 2017

    Clinical Informatics News | November was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Bracket, Johnson & Johnson, Bioclinica, and more.

    Dec 1, 2017
  • Deep Learning In The Clinic: Predicting Patient Prognosis

    Clinical Informatics News | In a paper published earlier this month on arXiv, and not yet peer-reviewed, Stanford researchers outlined how machine learning can be made to predict prognosis in a clinical setting.

    Dec 1, 2017
  • Apple Launches Virtual Heart Rhythm Study

    Clinical Informatics News Brief | Apple today launched the Apple Heart Study app, a study using Apple Watch’s heart rate sensor to collect data on irregular heart rhythms and notify users who may be experiencing atrial fibrillation (AFib).

    Nov 30, 2017
  • Alex Azar Addressing Drug Prices Would Be Top Priority At HHS

    STAT |  Alex Azar, President Trump's pick to lead the Health and Human Services Department, didn't mince words when he described his top priority for the agency, telling lawmakers Wednesday that drug prices are too high and must be lowered.

    Nov 29, 2017
  • About 11 Percent Of Drugs In Poor Countries Are Fake, U.N. Says

    STAT |  The medicines are likely responsible for the deaths of tens of thousands of children from diseases like malaria and pneumonia every year.

    Nov 28, 2017
  • As Health Care Changes, Insurers, Hospitals, and Drugstores Team Up

    The New York Times |  They seem like odd couples: Aetna, one of the nation's largest health insurers, is in talks to combine with CVS Health, which manages pharmacy benefits. The Cleveland Clinic, a highly regarded health system, joined forces with an insurance start-up, Oscar Health, to offer individuals a health plan in Ohio.

    Nov 27, 2017
  • Tackling The Internet Of Things In Healthcare

    Clinical Informatics News | Cambridge Healthtech Institute’s Inaugural Healthcare Internet of Things event in San Francisco next February aims to bring together constituents and stakeholders to share cases studies and pilot programs that showcase the healthcare industry’s collaborative efforts toward the adoption and implementation of IoT. Here are a few of the talks we have flagged on our agendas.

    Nov 21, 2017
  • Study Uses Real World Evidence To Replicate Pivotal Trial Results

    RAPS |  A study published in JAMA Internal Medicine on Monday was able to replicate the results of a large randomized controlled clinical trial for the blood pressure drug telmisartan using real world evidence gathered from insurance claims data.

    Nov 21, 2017
  • FDA Approves Telemedicine Programming For Cochlear Implants

    Clinical Informatics News Brief The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor and are comfortable with the programming process.

    Nov 17, 2017